75
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Effect of severe renal impairment on umeclidinium and umeclidinium/vilanterol pharmacokinetics and safety: a single-blind, nonrandomized study

, , , , &
Pages 15-23 | Published online: 18 Dec 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Timothy E Albertson, Willis S Bowman, Richart W Harper, Regina M Godbout & Susan Murin. (2019) Evidence-based review of data on the combination inhaler umeclidinium/vilanterol in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1251-1265.
Read now
Gaetano Caramori, Paolo Ruggeri, Paolo Casolari, Kian Fan Chung, Giuseppe Girbino & Ian M. Adcock. (2017) Fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 11:12, pages 955-967.
Read now
Matteo Ferrando, Diego Bagnasco, Fulvio Braido, Ilaria Baiardini, Giovanni Passalacqua, Francesca Puggioni, Gilda Varricchi & Giorgio Walter Canonica. (2017) Umeclidinium for the treatment of uncontrolled asthma. Expert Opinion on Investigational Drugs 26:6, pages 761-766.
Read now
Andrea S Melani. (2015) Long-acting muscarinic antagonists. Expert Review of Clinical Pharmacology 8:4, pages 479-501.
Read now

Articles from other publishers (1)

Chaoying Hu, Jingying Jia, Kelly Dong, Linda Luo, Kai Wu, Rashmi Mehta, Jack Peng, Yan Ren, Annette Gross & Hui Yu. (2015) Pharmacokinetics and Tolerability of Inhaled Umeclidinium and Vilanterol Alone and in Combination in Healthy Chinese Subjects: A Randomized, Open-Label, Crossover Trial. PLOS ONE 10:3, pages e0121264.
Crossref